Trial intelligence / Profile preview

Randomised placebo-controlled trial of rosuvastatin in systemic lupus erythematosus

2006-006214-16Phase 4Completed

Sponsor: Imperial College London
Start: Feb 2008
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries: 1

Overview

Phase 4, randomised, double-blind trial in systemic lupus erythematosus (SLE) and Carotid artery disease (CAD) comparing Crestor (rosuvastatin) arm with Placebo arm (2 arms). Primary endpoint: Change in bilateral carotid artery wall volume and distensibility. Started Feb 2008; status: completed.

Drugs

rosuvastatin

Conditions

systemic lupus erythematosus (SLE)Carotid artery disease (CAD)

Beyond the preview

Go deeper on 2006-006214-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006214-16.